SIM-0708

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameSIM-0708
Drug Alias NameSIM-0708SIM0708
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnti-Interleukin-4 receptor subunit alpha
TargetsInterleukin-4 receptor subunit alpha
Therapy Area/IndicationsAutoimmune DiseasesPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSimcere Pharmaceutical Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSimcere Pharmaceutical Group Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A